Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models (2023)
- Authors:
- USP affiliated authors: FERREIRA, MARCELO JOSÉ PENA - IB ; REGO, EDUARDO MAGALHÃES - FM ; LOTUFO, LETICIA VERAS COSTA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; NASCIMENTO, MARIANE CRISTINA DO - FM ; LIMA, KELI CRISTINA DE - FM ; VICARI, HUGO PASSOS - ICB ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP
- Unidades: IB; FM; ICB; FMRP
- DOI: 10.1182/blood-2023-189814
- Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; HEMATOLOGIA; QUIMIOTERAPIA COMBINADA; CÉLULAS CULTIVADAS DE TUMOR; PROLIFERAÇÃO CELULAR; NEOPLASIAS POR TIPO HISTOLÓGICO; APOPTOSE; DANO AO DNA; MITOCÔNDRIAS; PROTEÔMICA; ANTINEOPLÁSICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: American Society of Hematology
- Publisher place: Washington, DC
- Date published: 2023
- Source:
- Conference titles: 65th ASH Annual Meeting Abstracts
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
NASCIMENTO, Mariane Cristina do et al. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, v. 142, n. res. 604, p. 5751, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189814. Acesso em: 29 maio 2024. -
APA
Nascimento, M. C. do, Martins, D. A. P., Alcântara, G. A. S., Lima, K. C. de, Vicari, H. P., Huls, G. A., et al. (2023). Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, 142( res. 604), 5751. doi:10.1182/blood-2023-189814 -
NLM
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 maio 29 ] Available from: https://doi.org/10.1182/blood-2023-189814 -
Vancouver
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 maio 29 ] Available from: https://doi.org/10.1182/blood-2023-189814 - Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia
- Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia
- Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- Inibição farmacológica de ezrina reduz a viabilidade, a clonogenicidade e a ativação da via PI3K/AKT/mTOR em modelos celulares de leucemia mieloide aguda
- Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
- CDC7 (cell division cycle 7)
- STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells
- Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
Informações sobre o DOI: 10.1182/blood-2023-189814 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
